Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1992-04-10
1994-03-22
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514182, 552615, 552621, 552622, A61K 3156, C07J 100
Patent
active
052964817
ABSTRACT:
A method for controlling weight gain or promoting weight loss which includes the step of treating a subject with an effective weight gain controlling or weight loss promoting amount of a substituted .DELTA.5-Androstene which is biologically effective for controlling weight gain or promoting weight loss and biologically ineffective for promoting the synthesis of sex hormones. Steroids believed to provide the desired weight control/weight loss characteristics include:
REFERENCES:
patent: 4511511 (1985-04-01), Lewbart
patent: 4518595 (1985-05-01), Coleman et al.
patent: 4666888 (1987-05-01), Coleman et al.
patent: 4897390 (1990-01-01), Ruhe
patent: 4898694 (1990-02-01), Schwartz et al.
Lardy Henry A.
Partridge Bruce E.
Criares T. J.
Humanetics Corporation
Waddell Frederick E.
LandOfFree
Treatment process for promoting weight loss employing a substitu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment process for promoting weight loss employing a substitu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment process for promoting weight loss employing a substitu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437240